Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Director Dealing

13 Dec 2017 10:18

RNS Number : 2243Z
Ideagen PLC
13 December 2017
 

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

Purchase of shares by director

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that Alan Carroll, a non-executive director, yesterday purchased 21 ordinary shares in the Company at a price of 104.15 pence each as a result of the automatic reinvestment of the Company's recent dividend.

Following the purchase, Mr Carroll's beneficial interest has increased to 204,021 shares representing approximately 0.1% of the Company's issued share capital.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

Enquiries:

Ideagen plc

01629 699100

David Hornsby, Chief Executive

 

Graeme Spenceley, Finance Director

 

 

 

finnCap Limited

020 7220 0500

Stuart Andrews/Henrik Persson/James Thompson (Nomad)

 

Stephen Norcross (Corporate Broking)

 

 

 

 

 

 About Ideagen plc

Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in GRC (Governance, Risk and Compliance) and Content and Clinical solutions with a primary focus on organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete information lifecycle solutions that enable organisations to reduce risk, meet their regulatory and compliance standards, helping them to reduce costs and improve efficiency.

The Group has a customer base of over 3,000 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.

For further information please visit www.ideagen.com

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Alan Carroll

2.

Reason for the Notification

a)

Position/status

Non-executive director

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

104.15p

21

d)

Aggregated information:

· Aggregated volume

· Price

 

21 ordinary shares of 1p each purchased at 104.15p per share

e)

Date of the transaction

12th December 2017

f)

Place of the transaction

London Stock Exchange AIM market (XLON)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHMMMMZGFNGNZM
Date   Source Headline
25th Jun 20147:00 amRNSAcquisition of EIBS Ltd
5th Jun 20142:06 pmRNSHolding(s) in Company
3rd Jun 20147:00 amRNSIssue of ordinary shares
16th May 20147:00 amRNSIssue of ordinary shares
7th May 20147:00 amRNSTrading Update and Further NHS Contract Wins
17th Mar 20147:00 amRNSNHS Contract Wins
4th Mar 20147:00 amRNSContract Wins and Trading Update
20th Jan 201411:54 amRNSHolding(s) in Company
14th Jan 20147:00 amRNSHalf Yearly Report
3rd Jan 20144:41 pmRNSSecond Price Monitoring Extn
3rd Jan 20144:35 pmRNSPrice Monitoring Extension
17th Dec 20137:00 amRNSNotice of Results
20th Nov 20137:00 amRNSAcquisition of Pentana Ltd
6th Nov 20137:00 amRNSTrading update
30th Oct 201312:22 pmRNSAnnual Report & Accounts
29th Oct 20132:38 pmRNSResult of AGM
16th Oct 201312:02 pmRNSHolding(s) in Company
8th Oct 20137:00 amRNSIssue of ordinary shares
7th Oct 20137:00 amRNSNotice of AGM
9th Sep 20137:00 amRNSFurther Healthcare Contract Wins
16th Jul 20137:01 amRNSFinal Results
16th Jul 20137:00 amRNSNew Contract Win worth £300k
9th Jul 20137:00 amRNSNotice of Results
3rd Jul 20137:00 amRNSAcquisition of MSS Management Systems Services Ltd
10th Jun 20137:00 amRNSStrategic Partnership
10th May 20131:15 pmRNSDirector/PDMR Shareholding
10th May 20137:00 amRNSVA Contract Update
7th May 20137:00 amRNSTrading Update
22nd Apr 20137:00 amRNSContract Wins and Trading Update
19th Mar 20132:39 pmRNSHolding(s) in Company
12th Mar 20137:00 amRNSContract Wins and Board Change
31st Jan 20137:00 amRNSIssue of Equity and Award of Options
22nd Jan 20137:00 amRNSHalf Yearly Report
16th Jan 20137:00 amRNSHealthcare Contract Wins and New Appointments
16th Jan 20137:00 amRNSHolding(s) in Company
10th Jan 20137:00 amRNSNotice of Results
7th Jan 201312:55 pmRNSResult of General Meeting and Issue of Equity
24th Dec 20121:07 pmRNSHolding(s) in Company
24th Dec 201212:21 pmRNSHolding(s) in Company
19th Dec 20123:00 pmRNSPosting of Circular and Notice of General Meeting
17th Dec 20127:00 amRNSPlacing and acquisition
29th Nov 20127:00 amRNSTrading Update
9th Nov 20124:16 pmRNSHolding(s) in Company
31st Oct 20121:40 pmRNSResult of AGM
10th Oct 20125:57 pmRNSHolding(s) in Company
8th Oct 201211:42 amRNSNotice of AGM and Change of Address
3rd Sep 20128:25 amRNSHolding(s) in Company
29th Aug 20127:00 amRNSHolding(s) in Company
29th Aug 20127:00 amRNSContract Win
24th Jul 20127:00 amRNSPreliminary Results 30 April 2012

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.